"Nuclear Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins found in the nucleus of a cell. Do not confuse with NUCLEOPROTEINS which are proteins conjugated with nucleic acids, that are not necessarily present in the nucleus.
| Descriptor ID |
D009687
|
| MeSH Number(s) |
D12.776.660
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nuclear Proteins".
Below are MeSH descriptors whose meaning is more specific than "Nuclear Proteins".
This graph shows the total number of publications written about "Nuclear Proteins" by people in this website by year, and whether "Nuclear Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 11 | 3 | 14 |
| 1997 | 13 | 3 | 16 |
| 1998 | 7 | 6 | 13 |
| 1999 | 9 | 10 | 19 |
| 2000 | 22 | 7 | 29 |
| 2001 | 11 | 8 | 19 |
| 2002 | 15 | 9 | 24 |
| 2003 | 19 | 8 | 27 |
| 2004 | 12 | 12 | 24 |
| 2005 | 15 | 10 | 25 |
| 2006 | 12 | 5 | 17 |
| 2007 | 10 | 3 | 13 |
| 2008 | 5 | 7 | 12 |
| 2009 | 18 | 16 | 34 |
| 2010 | 17 | 10 | 27 |
| 2011 | 13 | 15 | 28 |
| 2012 | 23 | 9 | 32 |
| 2013 | 19 | 10 | 29 |
| 2014 | 16 | 11 | 27 |
| 2015 | 17 | 7 | 24 |
| 2016 | 12 | 7 | 19 |
| 2017 | 11 | 9 | 20 |
| 2018 | 14 | 10 | 24 |
| 2019 | 11 | 4 | 15 |
| 2020 | 4 | 4 | 8 |
| 2021 | 4 | 7 | 11 |
| 2022 | 1 | 8 | 9 |
| 2023 | 1 | 6 | 7 |
| 2024 | 6 | 6 | 12 |
| 2025 | 8 | 1 | 9 |
| 2026 | 3 | 4 | 7 |
To return to the timeline,
click here.
Below are the most recent publications written about "Nuclear Proteins" by people in Profiles.
-
Asymmetric chromatin accessibility underlies anterior-posterior axis specification in moth fly embryos. PLoS Biol. 2026 Aug; 24(8):e3003896.
-
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA. Am J Hematol. 2026 Sep; 101(9):2246-2257.
-
Genotype-immunophenotype relationships in NPM1-mutated AML clonal evolution uncovered by single-cell multiomic analysis. Blood. 2026 06 25; 147(26):3209-3216.
-
Active RNA synthesis patterns nuclear condensates. Cell Syst. 2026 Jul 15; 17(7):101613.
-
Pontocerebellar hypoplasia linked mutations of the deadenylase Target of EGR1 (TOE1) impair thermal stability, ribonuclease activity, and oligomerization. J Biol Chem. 2026 07; 302(7):113186.
-
Independent control of neurogenesis and dorsoventral patterning by NKX2-2. Genes Dev. 2026 03 02; 40(5-6):384-395.
-
FBXO11 suppression rewires an NPM1-centered interactome influencing the progression of myelodysplastic syndrome. J Clin Invest. 2026 Jan 16; 136(2).
-
Emerin expression stratification across breast cancer subtypes. Cancer Treat Res Commun. 2025; 45:101037.
-
Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study. Blood. 2025 Aug 28; 146(9):1065-1077.
-
Development of Emerin mRNA Lipid Nanoparticles to Rescue Myogenic Differentiation. Int J Mol Sci. 2025 Aug 12; 26(16).